NEW YORK, July 19, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ:SIGA), a commercial-stage pharmaceutical company, today announced that the U.S. Department of Health and Human Services exercised a procurement option for the delivery of approximately $113 million of oral TPOXX® treatment courses. This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements relating to SIGA's future busin ...

The most recent trading session ended with Siga Technologies Inc. (SIGA) standing at $9.06, reflecting a +0.55% shift from the previouse trading day's closing. The stock's performance was ahead of the S&P 500's daily loss of 0.78%. Meanwhile, the Dow lost 1.29%, and the Nasdaq, a tech-heavy index, lost 0.7%. Prior to today's trading, shares of the company had gained 42.56% over the past month. This has outpaced the Medical sector's gain of 2.23% and the S&P 500's gain of 2.14% in that time. The investment c ...

The most recent trading session ended with Siga Technologies Inc. (SIGA) standing at $8.69, reflecting a +1.88% shift from the previouse trading day's closing. The stock exceeded the S&P 500, which registered a loss of 0.88% for the day. On the other hand, the Dow registered a gain of 0.08%, and the technology-centric Nasdaq decreased by 1.95%. Investors will be eagerly watching for the performance of Siga Technologies Inc. in its upcoming earnings disclosure. It is also important to note the recent changes ...

Prior to today's trading, shares of the company had gained 0.78% over the past month. This has outpaced the Medical sector's loss of 0.44% and lagged the S&P 500's gain of 4.08% in that time. Regarding the entire year, the Zacks Consensus Estimates forecast earnings of $1.18 per share and revenue of $177.56 million, indicating changes of +24.21% and +26.9%, respectively, compared to the previous year. Based on our research, we believe these estimate revisions are directly related to near-team stock moves. T ...

A spokesperson from the Ministry of Health, Brunei Darussalam said, "We are pleased to support the ASEANwide effort to prepare for and respond to public health events. Ensuring adequate supply and access to countermeasures is a vital part of preparedness and this initiative by the region strengthens our collective health security against the Mpox threat." ASEAN, established in August 1967, is comprised of Brunei Darussalam, Cambodia, Indonesia, Lao PDR, Malaysia, Myanmar, Philippines, Singapore, Thailand, a ...

NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on global health and infectious diseases, announced today an agreement to expand access to TPOXX (tecovirimat) to the member states in the Association of Southeast Asian Nations (ASEAN), a political and economic union in the region. This agreement, which was signed by the Ministry of Health of the Government of Brunei Darussalam on behalf of ASEAN Health Sector, is significant as it reflect ...

SIGA Technologies, Inc. (NASDAQ:SIGA) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Diem Nguyen - Chief Executive Officer Dan Luckshire - Chief Financial Officer Conference Call Participants Soo Romanoff - Edison Group Brian Adams - Carter, Terry Operator Welcome to the SIGA Business Update Call. Before we turn the call over to SIGA management, please note that any forward-looking statements made during this call are based on management’s current expectations and observations ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2024 Or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ________ to ___________ (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 31 East 62nd Street ...

NEW YORK, May 7, 2024 -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three months ended March 31, 2024. "SIGA delivered strong results in the first quarter, with product revenues of $24 million and pre-tax operating income of $11 million, both up over the comparable quarter in 2023," said Diem Nguyen, Chief Executive Officer. "First quarter financial performance is a testament to our focus on financial and operational exc ...

SIGA Technologies, Inc. (NASDAQ:SIGA) Q4 2023 Earnings Conference Call March 12, 2024 4:30 PM ET Company Participants Diem Nguyen - Chief Executive Officer Daniel Luckshire - Executive Vice President and Chief Financial Officer Conference Call Participants Soo Romanoff - Edison Group Lance Kimbrough - Ivy Creek Capital Operator Welcome to the SIGA Business Update Call. Before we turn the call over to SIGA management, please note that any forward-looking statements made during this call are based on manageme ...